Insider Ledger

SPRO insider buying and SEC filings, explained

Spero Therapeutics, Inc. · CIK 1701108

Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov

Insider activity in the last 12 months

Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$552K
Planned sales (10b5-1)
$0

Insider purchases and sales, last 12 months

TradedTypeWhat was filedSource
May 4, 2026SaleEsther Rajavelu (CEO) sold 25,240 shares at $2.51 ($63K). Holdings down 2% to 986,851 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed May 6, 2026
Feb 6, 2026SaleEsther Rajavelu (CEO) sold 87,917 shares at $2.36 ($207K). Holdings down 8% to 1,012,091 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Feb 9, 2026
Feb 6, 2026SaleTimothy Keutzer (President / COO) sold 18,652 shares at $2.36 ($44K). Holdings down 2% to 742,506 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Feb 9, 2026
Feb 2–4, 2026SaleTimothy Keutzer (President / COO) sold 46,586 shares between Feb 2 and Feb 4 at about $2.17 ($101K). Holdings down 6% to 761,158 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Feb 5, 2026
Feb 2, 2026SaleEsther Rajavelu (CEO) sold 18,442 shares at $2.20 ($41K). Holdings down 2% to 1,100,008 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Feb 4, 2026
Nov 7, 2025SaleEsther Rajavelu (CEO) sold 40,270 shares at $2.37 ($95K). Holdings down 4% to 869,450 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Nov 12, 2025

10 routine transactions (such as grants, option exercises or tax withholding) are not listed.

Cluster buys

No cluster buys in the last 12 months.

Red flags

No red flags in the last 12 months.

Key events

No key events in the last 12 months.

8-K filings, last 12 months

No 8-K filings in the last 12 months.

Red flags are objective triggers only: the item or form filed, never an opinion.

Follow SPRO in the Insider Ledger app

A plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.

Get the app